Company Profiles

driven by the PitchBook Platform

ApopLogic Pharmaceuticals

Description

Developer of therapeutic products that target apoptotic cell death pathways. The company offers Brecept for cancers; Cytonil to treat Sezary leukemia, cutaneous T cell lymphoma, and psoriasis; and Fasaret, a therapy for the treatment of cancers.

2006

Founded

PRIVATE

Status

1-10

Employees

Accelerator/Inc

Latest Deal Type

$795k

Total Amount Raised

4

Investors

Description

Developer of therapeutic products that target apoptotic cell death pathways. The company offers Brecept for cancers; Cytonil to treat Sezary leukemia, cutaneous T cell lymphoma, and psoriasis; and Fasaret, a therapy for the treatment of cancers.

Website:

www.apoplogic.com

Ownership Status

Privately Held (backing)

Financing Status

Angel-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals

Primary Office

12635 East Montview Boulevard Suite 100 Aurora, CO 80045United States
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore ApopLogic Pharmaceuticals's full profile, request a free trial.

    ApopLogic Pharmaceuticals Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    ApopLogic Pharmaceuticals Investors (4)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Life Science AngelsAngel GroupMinority000 0000000 0000
    University License Equity HoldingCorporationMinority000 0000000 0000
    U.S. Department of Health and Human ServicesGovernmentMinority000 0000000 0000
    Xandex InvestmentsVenture CapitalMinority000 0000000 0000
    Life Science Angels Angel Group
    University License Equity Holding Corporation
    U.S. Department of Health and Human Services Government
    Xandex Investments Venture Capital

    ApopLogic Pharmaceuticals Executive Team (1)

    NameTitleBoard
    Seat
    Contact
    Info
    Richard Duke Ph.DPresident & Chief Executive Officer
    Richard Duke Ph.D President & Chief Executive Officer
    Request full access to PitchBook